| Medicare Noridian | Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (58181) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (58183) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (58973) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (58996) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (59509) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (59835) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (59872) | 2026-01-26 |
| BCBS Highmark Penn Medicare Advantage | Knee Orthoses | 2026-01-25 |
| BCBS Florida Coverage Guidelines | Whole Body Computed Tomography (CT) (04-70450-25) | 2026-01-23 |
| HealthPartners | Early intensive developmental and behavioral | 2026-01-23 |